- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 125,860 | 19.07.24 21:08:10 | +1,610 | +1,30% | 125,840 | 125,860 | 125,300 | 124,250 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 100,649 | 19.07.24 20:56:25 | +1,689 | +1,71% | 100,600 | 100,850 | 100,500 | 98,960 |
